Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‐4) and programmed death‐ligand 1 (PD‐L1) inhibitors have effectively prolonged the OS of patients with advanced HCC (including distant metastasis).7 This evidence concerns the gene CD274 and hepatocellular carcinoma.